Reprogrammed astrocytes display higher neurogenic competence, migration ability and cell death resistance than reprogrammed fibroblasts.
Xiaohuan XiaChunhong LiYi WangXiaobei DengYizhao MaLu DingJialin C ZhengPublished in: Translational neurodegeneration (2020)
The direct reprogramming of somatic cells into induced neural progenitor cells (iNPCs) has been envisioned as a promising approach to overcome ethical and clinical issues of pluripotent stem cell transplantation. We previously reported that astrocyte-derived induced pluripotent stem cells (iPSCs) have more tendencies for neuronal differentiation than fibroblast-derived iPSCs. However, the differences of neurogenic potential between astrocyte-derived iNPCs (AiNPCs) and iNPCs from non-neural origins, such as fibroblast-derived iNPCs (FiNPCs), and the underlying mechanisms remain unclear. Our results suggested that AiNPCs exhibited higher differentiation efficiency, mobility and survival capacities, compared to FiNPCs. The whole transcriptome analysis revealed higher activities of TGFβ signaling in AiNPCs, versus FiNPCs, following a similar trend between astrocytes and fibroblasts. The higher neurogenic competence, migration ability, and cell death resistance of AiNPCs could be abrogated using TGFβ signaling inhibitor LY2157299. Hence, our study demonstrates the difference between iNPCs generated from neural and non-neural cells, together with the underlying mechanisms, which, provides valuable information for donor cell selection in the reprogramming approach.
Keyphrases
- cell death
- cell cycle arrest
- stem cell transplantation
- induced pluripotent stem cells
- induced apoptosis
- spinal cord injury
- high dose
- transforming growth factor
- single cell
- healthcare
- stem cells
- gene expression
- endoplasmic reticulum stress
- diabetic rats
- cell proliferation
- climate change
- signaling pathway
- mesenchymal stem cells
- brain injury
- decision making
- cerebral ischemia